Bivin & Associates’s Axcelis ACLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$1K Hold
20
﹤0.01% 241
2022
Q1
$2K Hold
20
﹤0.01% 235
2021
Q4
$1K Buy
+20
New +$1.19K ﹤0.01% 274

Other funds holding ACLS

Bivin & Associates's ACLS Position: Q2 2022 in Review

Bivin & Associates held its Axcelis (ACLS) position steady in Q2 2022 at 20 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #241.

Bivin & Associates first reported a position in ACLS in Q4 2021 and has held it in 3 quarters since. The position peaked at $2K in Q1 2022. 276 funds tracked by Wall St. Rank hold ACLS as of Q2 2022.

  • Bivin & Associates held 20 shares of Axcelis worth $1K as of Q2 2022.
  • Bivin & Associates left its Axcelis share count unchanged in Q2 2022.
  • Axcelis made up ﹤0.01% of Bivin & Associates's portfolio in Q2 2022, its #241 holding.
  • Bivin & Associates first reported a position in Axcelis in Q4 2021 and has held it in 3 quarters since.
  • Bivin & Associates's Axcelis position peaked at $2K in Q1 2022.
  • 276 funds tracked by Wall St. Rank held Axcelis as of Q2 2022.

Based on Bivin & Associates's 13F filing for Q2 2022, filed 11 Aug 2022.